ALS Full Year results

• Revenue of $3.32 billion, an increase of 10.7% led by strong organic growth in Commodities, contrasting mixed growth in Life Sciences. • Underlying EBIT2 increased by 19.3% to $599.0 million, with the underlying EBIT margin accelerating by 129 bps to 18.0%. The margin improvement was led by strong growth in Commodities margins of 167 bps, and further solid improvement in Life Sciences of 55 bps.